BIT.BIO
Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. This has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the... cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
BIT.BIO
Industry:
Biotechnology Commercial Health Care
Founded:
2016-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.bit.bio
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
144.96 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Tag Manager Amazon Google Maps Cloudflare COVID-19 Cloudflare Network Error Logging Cloudflare SSL
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
HealthVerity
HealthVerity powers the discovery, licensing, and linkage of traditional and emerging healthcare data.
Current Advisors List
Current Employees Featured
Founder
Investors List
Resilience
Resilience investment in Series B - bit.bio
Metaplanet Holdings
Metaplanet Holdings investment in Series B - bit.bio
ArchVentures SA
ArchVentures SA investment in Series B - bit.bio
Tencent
Tencent investment in Series B - bit.bio
Puhua Capital
Puhua Capital investment in Series B - bit.bio
Charles River Laboratories International
Charles River Laboratories International investment in Series B - bit.bio
Milad Alucozai
Milad Alucozai investment in Series B - bit.bio
Foresite Capital
Foresite Capital investment in Series B - bit.bio
Rick Klausner
Rick Klausner investment in Series A - bit.bio
BlueYard Capital
BlueYard Capital investment in Series A - bit.bio
Official Site Inspections
http://www.bit.bio Semrush global rank: 1.54 M Semrush visits lastest month: 16.98 K
- Host name: 199.60.103.36
- IP address: 199.60.103.36
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto